88 related articles for article (PubMed ID: 17212810)
21. Generation of infectious feline immunodeficiency virus (FIV) encoding FIV/human immunodeficiency virus chimeric protease.
Lin YC; Torbett BE; Elder JH
J Virol; 2010 Jul; 84(13):6799-809. PubMed ID: 20410281
[TBL] [Abstract][Full Text] [Related]
22. FIV Gag: virus assembly and host-cell interactions.
Luttge BG; Freed EO
Vet Immunol Immunopathol; 2010 Mar; 134(1-2):3-13. PubMed ID: 19910057
[TBL] [Abstract][Full Text] [Related]
23. A role for the aspartyl protease from the human immunodeficiency virus type 1 (HIV-1) in the orchestration of virus assembly.
Navia MA; McKeever BM
Ann N Y Acad Sci; 1990; 616():73-85. PubMed ID: 2078037
[TBL] [Abstract][Full Text] [Related]
24. Relationships of human immunodeficiency virus protease with eukaryotic aspartic proteases.
Lin XL; Lin YZ; Tang J
Methods Enzymol; 1994; 241():195-224. PubMed ID: 7854179
[No Abstract] [Full Text] [Related]
25. Crystal structure of an FIV/HIV chimeric protease complexed with the broad-based inhibitor, TL-3.
Heaslet H; Lin YC; Tam K; Torbett BE; Elder JH; Stout CD
Retrovirology; 2007 Jan; 4():1. PubMed ID: 17212810
[TBL] [Abstract][Full Text] [Related]
26. Structural studies of FIV and HIV-1 proteases complexed with an efficient inhibitor of FIV protease.
Li M; Morris GM; Lee T; Laco GS; Wong CH; Olson AJ; Elder JH; Wlodawer A; Gustchina A
Proteins; 2000 Jan; 38(1):29-40. PubMed ID: 10651036
[TBL] [Abstract][Full Text] [Related]
27. Structural basis for distinctions between substrate and inhibitor specificities for feline immunodeficiency virus and human immunodeficiency virus proteases.
Lin YC; Beck Z; Morris GM; Olson AJ; Elder JH
J Virol; 2003 Jun; 77(12):6589-600. PubMed ID: 12767979
[TBL] [Abstract][Full Text] [Related]
28. Analysis of the S3 and S3' subsite specificities of feline immunodeficiency virus (FIV) protease: development of a broad-based protease inhibitor efficacious against FIV, SIV, and HIV in vitro and ex vivo.
Lee T; Laco GS; Torbett BE; Fox HS; Lerner DL; Elder JH; Wong CH
Proc Natl Acad Sci U S A; 1998 Feb; 95(3):939-44. PubMed ID: 9448264
[TBL] [Abstract][Full Text] [Related]
29. Toward a universal inhibitor of retroviral proteases: comparative analysis of the interactions of LP-130 complexed with proteases from HIV-1, FIV, and EIAV.
Kervinen J; Lubkowski J; Zdanov A; Bhatt D; Dunn BM; Hui KY; Powell DJ; Kay J; Wlodawer A; Gustchina A
Protein Sci; 1998 Nov; 7(11):2314-23. PubMed ID: 9827997
[TBL] [Abstract][Full Text] [Related]
30. Free R value: a novel statistical quantity for assessing the accuracy of crystal structures.
Brünger AT
Nature; 1992 Jan; 355(6359):472-5. PubMed ID: 18481394
[TBL] [Abstract][Full Text] [Related]
31. Altered gag polyprotein cleavage specificity of feline immunodeficiency virus/human immunodeficiency virus mutant proteases as demonstrated in a cell-based expression system.
Lin YC; Brik A; de Parseval A; Tam K; Torbett BE; Wong CH; Elder JH
J Virol; 2006 Aug; 80(16):7832-43. PubMed ID: 16873240
[TBL] [Abstract][Full Text] [Related]
32. Substrate specificity in HIV-1 protease by a biased sequence search method.
Ozer N; Haliloglu T; Schiffer CA
Proteins; 2006 Aug; 64(2):444-56. PubMed ID: 16741993
[TBL] [Abstract][Full Text] [Related]
33. The influence of macromolecular crowding on HIV-1 protease internal dynamics.
Minh DD; Chang CE; Trylska J; Tozzini V; McCammon JA
J Am Chem Soc; 2006 May; 128(18):6006-7. PubMed ID: 16669648
[TBL] [Abstract][Full Text] [Related]
34. Mechanism of drug resistance revealed by the crystal structure of the unliganded HIV-1 protease with F53L mutation.
Liu F; Kovalevsky AY; Louis JM; Boross PI; Wang YF; Harrison RW; Weber IT
J Mol Biol; 2006 May; 358(5):1191-9. PubMed ID: 16569415
[TBL] [Abstract][Full Text] [Related]
35. Structural insights into the mechanisms of drug resistance in HIV-1 protease NL4-3.
Heaslet H; Kutilek V; Morris GM; Lin YC; Elder JH; Torbett BE; Stout CD
J Mol Biol; 2006 Mar; 356(4):967-81. PubMed ID: 16403521
[TBL] [Abstract][Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
